Adial Pharmaceuticals (ADIL)
(Delayed Data from NSDQ)
$0.97 USD
-0.03 (-2.56%)
Updated Oct 1, 2024 03:59 PM ET
After-Market: $0.96 -0.01 (-1.38%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth B Momentum C VGM
Cash flow Statements
Fiscal Year End for Adial Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -7.00 | -12.73 | -19.42 | -10.89 | -8.59 |
Depreciation/Amortization & Depletion | 0.00 | 0.06 | 0.06 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | -0.79 | -1.37 | 1.46 | 1.25 | 0.21 |
Net Cash from Discontinued Operations | -1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.99 | 2.85 | 5.95 | 2.01 | 2.04 |
Net Cash From Operating Activities | -6.81 | -11.19 | -11.95 | -7.63 | -6.34 |
Property & Equipment | 0.00 | 0.00 | -0.06 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 1.50 | 0.00 | 0.03 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | -0.35 | 0.00 |
Net Cash from Investing Activities | 1.50 | 0.00 | -0.03 | -0.35 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.13 | 0.00 | 13.64 | 5.61 | 9.25 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 9.12 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 4.13 | 9.13 | 13.64 | 5.61 | 9.25 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -1.17 | -2.06 | 1.66 | -2.38 | 2.91 |
Cash at Beginning of Period | 4.00 | 6.06 | 4.40 | 6.78 | 3.87 |
Cash at End of Period | 2.83 | 4.00 | 6.06 | 4.40 | 6.78 |
Diluted Net EPS | -3.60 | -12.75 | -26.00 | -21.75 | -21.75 |
Fiscal Year End for Adial Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -8.93 | -6.48 | -7.00 | -5.10 | -3.75 |
Depreciation/Amortization & Depletion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | -0.14 | -0.03 | -0.79 | -1.02 | -0.71 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | -1.00 | -0.99 | -0.99 |
Other Operating Activities | 5.31 | 4.88 | 1.99 | 1.52 | 1.25 |
Net Cash From Operating Activities | -3.77 | -1.63 | -6.81 | -5.58 | -4.19 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 1.50 | 1.15 | 0.80 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | 1.50 | 1.15 | 0.80 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.24 | 3.82 | 4.13 | 0.75 | 0.61 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 4.24 | 3.82 | 4.13 | 0.75 | 0.61 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 0.46 | 2.20 | -1.17 | -3.69 | -2.78 |
Cash at Beginning of Period | 2.83 | 2.83 | 4.00 | 4.00 | 4.00 |
Cash at End of Period | 3.29 | 5.03 | 2.83 | 0.32 | 1.22 |
Diluted Net EPS | -0.59 | -2.19 | -0.63 | -1.18 | 0.96 |